Acorda Therapeutics Accounts Receivable:
23.29M for Dec. 31, 2012Acorda Therapeutics Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 23.29M |
| Dec. 31, 2012 | 26.33M |
| Sept. 30, 2012 | 23.23M |
| June 30, 2012 | 23.61M |
| March 31, 2012 | 21.53M |
| Dec. 31, 2011 | 22.83M |
| Sept. 30, 2011 | 20.61M |
| June 30, 2011 | 23.42M |
| March 31, 2011 | 23.80M |
| Dec. 31, 2010 | 22.27M |
| Sept. 30, 2010 | 18.23M |
| June 30, 2010 | 17.93M |
| March 31, 2010 | 7.944M |
| Dec. 31, 2009 | 5.739M |
| Sept. 30, 2009 | 4.246M |
| June 30, 2009 | 5.331M |
| March 31, 2009 | 4.603M |
| Dec. 31, 2008 | 4.622M |
| Sept. 30, 2008 | 4.017M |
| June 30, 2008 | 4.957M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
ACOR Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Discovery Laboratories | |
| Biogen Idec | 753.61M |
| Osiris Therapeutics | 5.346M |
ACOR Accounts Receivable Rankings
| Overall |
71st percentile 2269 of 8002 |
| Sector |
72nd percentile 187 of 684 in Healthcare |
| Industry |
89th percentile 27 of 248 in Biotechnology |
ACOR Accounts Receivable Range, Past 5 Years
| Minimum | 4.017M | Sep 2008 |
| Maximum | 26.33M | Dec 2012 |
| Average | 15.43M |
